Teclistamab Biosimilar - Research Grade

Human

CD3 + BCMA

5mg/ml

Human IgG4 (S228P/F234A/L235A)-lambda1

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects CD3xBCMA

Blue ice

B-cell maturation antigen (BCMA) marks plasma cells while CD3 mediates T-cell recruitment, a combination at the centre of multiple-myeloma immunotherapy research. This bispecific reagent is an unconjugated, non-therapeutic analog of teclistamab bridging CD3 and BCMA, supplied for research use only (RUO). It is manufactured to in vivo standards, presents low endotoxin, and is produced in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories. Applications include functional assays, T-cell-redirected killing studies, defined controls, and in vivo plasma-cell-malignancy models, with reproducible bispecific performance suited to extended, heavy-usage research campaigns.

JNJ-64007957;CD3e, CD3 epsilon;TNF receptor superfamily member 17, BCMA, tumor necrosis factor receptor superfamily, member 17, BCM, CD269, TNFRSF13A;TNFRSF17

P07766;Q02223

ICH3002

https://www.imgt.org/mAb-DB/